Back to Search Start Over

Visual Acuity Outcome over Time in Non-Infectious Uveitis.

Authors :
Pistilli, Maxwell
Joffe, Marshall M.
Gangaputra, Sapna S.
Pujari, Siddharth S.
Jabs, Douglas A.
Levy-Clarke, Grace A.
Nussenblatt, Robert B.
Rosenbaum, James T.
Sen, H. Nida
Suhler, Eric B.
Thorne, Jennifer E.
Bhatt, Nirali P.
Foster, C. Stephen
Begum, Hosne
Fitzgerald, Tonetta D.
Dreger, Kurt A.
Altaweel, Michael M.
Holbrook, Janet T.
Kempen, John H.
Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Research Group
Source :
Ocular Immunology & Inflammation. 2021, Vol. 29 Issue 6, p1064-1071. 8p.
Publication Year :
2021

Abstract

Introduction: We evaluated visual acuity (VA) over 5 years in a subspecialty noninfectious uveitis population.Methods: Retrospective data from 5,530 noninfectious uveitis patients with anterior, intermediate, posterior or panuveitis were abstracted by expert reviewers. Mean VA was calculated using inverse probability of censoring weighting to account for losses to follow-up.Results: Patients were a median of 41 years old, 65% female, and 73% white. Initial mean VA was worse among panuveitis (20/84) than posterior (20/64), intermediate (20/47), and anterior (20/37) uveitides. On average, mean VA improved by 0.62, 0.51, 0.37, and 0.26 logMAR-equivalent lines over 2 years, respectively (each P < .001), then remained stable, except posterior uveitis mean VA worsened to initial levels.Conclusion: Mean VA of uveitic eyes improved and, typically, improvement was sustained under uveitis subspecialty care. Because VA tends to improve under tertiary care, mean VA change appears a better outcome for clinical studies than time-to-loss of VA. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09273948
Volume :
29
Issue :
6
Database :
Academic Search Index
Journal :
Ocular Immunology & Inflammation
Publication Type :
Academic Journal
Accession number :
154758241
Full Text :
https://doi.org/10.1080/09273948.2019.1687733